Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • Signal News Directory
  • Pain & Anaesthesia

Pain & Anaesthesia

  • Regulatory

AbbVie receives EC approval for Aquipta to treat migraine

pharminent June 3, 2026
  • Regulatory

VERTANICAL’s VER-01 gains FDA breakthrough status for low back pain

pharminent May 19, 2026
  • Commercial

A year after Vertex’s big launch, pain drug research faces a pivotal moment

pharminent May 12, 2026
  • M&A / Deals

AbbVie enters world of pain in up to $715M deal with China’s Haisco

pharminent April 13, 2026
  • M&A / Deals

AbbVie bets on Chinese biopharma’s pain pipeline in $745m bid

pharminent April 13, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.